back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-27 14:01 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$308,400
+60,000 vol $5.14 each |
310,000 | |
| Filed 2024-05-22 23:23 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$277,200
+70,000 vol $3.96 each |
250,000 | |
| Filed 2024-04-01 08:55 Tx date 2024-02-27 |
$CCCP.
Coco Pool Corp. |
Kowalski, Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-20,000 vol |
88,709 | |
| Filed 2023-08-20 01:08 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$56,000
+8,000 vol $7.00 each |
8,000 | |
| Filed 2023-08-20 01:07 Tx date 2023-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-19 19:30 Tx date 2023-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,231,200
+180,000 vol $6.84 each |
180,000 | |
| Filed 2023-05-19 19:28 Tx date 2023-05-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-29 Tx date 2016-03-15 |
$ABUS
Arbutus Biopharma Corporation |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$334,900
+85,000 vol $3.94 each |
260,000 | |
| Filed 2015-12-23 Tx date 2015-12-03 |
$TKMR
Arbutus Biopharma Corporation |
Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
175,000 |